Orange Book product · Generic (ANDA)
LATANOPROST
LATANOPROST
At a glance
Nov 26, 2024
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 26, 2024
1 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
LATANOPROST
Strength
0.005%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
ANDA 218257
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LATANOPROST
- 2022IYUZEHBrand (NDA)
NDA 216472 · THEA PHARMA
- 2018XELPROSBrand (NDA)
NDA 206185 · SUN PHARM
- 1996XALATANBrand (NDA)
NDA 020597 · UPJOHN
- 2025LATANOPROSTGeneric (ANDA)
ANDA 220360 · MANKIND PHARMA
- 2025LATANOPROSTGeneric (ANDA)
ANDA 219306 · MICRO LABS
- 2019LATANOPROSTGeneric (ANDA)
ANDA 206519 · EUGIA PHARMA
- 2016LATANOPROSTGeneric (ANDA)
ANDA 202442 · FDC LTD
- 2013LATANOPROSTGeneric (ANDA)
ANDA 202077 · CARNEGIE
- 2011LATANOPROSTGeneric (ANDA)
ANDA 090887 · EPIC PHARMA LLC
- 2011LATANOPROSTGeneric (ANDA)
ANDA 200925 · AMRING PHARMS
- 2011LATANOPROSTGeneric (ANDA)
ANDA 077697 · APOTEX INC
- 2011LATANOPROSTGeneric (ANDA)
ANDA 201006 · BAUSCH AND LOMB
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
